Citations

Mayo Clinic

Showing 10 of 108572 citations.

Introduction to the Special Issue on Sport Concussion: Clinical Best Practices for Assessment and Management
Mainwaring, Lynda , Trenerry, Max R.

Journal of Clinical Sport Psychology | August 10, 2016 | Volume: 6 | Issue: 3 | Pages: 203-206

10.1123/jcsp.6.3.203 Get It

This current special issue of the Journal of Clinical Sport Psychology was conceived and developed to provide a resource for clinicians who have contact with athletes who are at risk for or have sustained a concussion during sport participation. The special issue is part of an exciting two-issue series. This first installment contains papers from leaders in the field of sport concussion who review the frequency and mechanisms of concussion, models for managing concussion, the emotional aspects of concussion in sport, practical examples from a model sport concussion clinic, and the importance of sport concussion education and prevention. As Guest Editors, we hope that this timely and unique special series will be used by clinicians who help care for athletes and their families who have experienced concussion in their sport life.
Stereotactic Radiosurgery for Cystic Vestibular Schwannomas
Frisch, Christopher D., Jacob, Jeffrey T. , Carlson, Matthew L. , Foote, Robert L. , Driscoll, Colin L. W., Neff, Brian A., Pollock, Bruce E. , Link, Michael J.

Neurosurgery | August 10, 2016 | Volume: 80 | Issue: 1 | Pages: 112-118

10.1227/neu.0000000000001376 | PMID 27509069 Get It

Abstract BACKGROUND: The optimum treatment for cystic vestibular schwannoma (VS) remains controversial. Anecdotally, many treating physicians feel that cystic VSs do not respond to stereotactic radiosurgery (SRS) as well as noncystic tumors. OBJECTIVE: To present outcomes after treatment of predominantly cystic VS with SRS. METHODS: A prospectively maintained clinical database of patients undergoing Gamma Knife (Elekta Instruments, Stockholm, Sweden) radiosurgery (GKRS) for VS at a single tertiary academic referral center was retrospectively reviewed. Patients diagnosed with cystic VS who were treated with GKRS between 1997 and 2014 were analyzed. Size-matched solid tumors treated with GKRS during this period were selected as controls. RESULTS: Twenty patients (12 women; median age at treatment, 56 years; range, 36-85 years) with cystic VS met inclusion criteria. The median radiologic follow-up within the cystic group was 63 months (range, 17-201 months), and the median change in tumor size was −4.9 mm (range, −10.4 to 9.3 mm). Sixteen tumors (80%) shrank, 2 (10%) remained stable, and 2 (10%) enlarged, accounting for a tumor control rate of 90%. The median radiologic follow-up in the noncystic control group was 67 months (range, 6-141 months), and the median change in size was −2.0 mm (range, −10.4 to 2.5 mm). Tumor control in the solid group was 90%. Comparing only those tumors that decreased in size showed that there was a trend toward a greater reduction within the cystic group ( P = .05). CONCLUSION: The present study demonstrates that tumor control after SRS for cystic VS may not differ from that of noncystic VS in selected cases.
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study
Zacharia, Brad E. , Cloney, Michael , Sonabend, Aarón , Showers, Christopher R. , Ebiana, Victoria, Nazarian, Matthew , Swanson, Kristin R. , Baldock, Anne, Brem, Henry , Bruce, Jeffrey N. , Butler, William E. , Orringer, Daniel A. , Roberts, David W. , Sagher, Oren , Sanai, Nader , Schwartz, Theodore H. , Silbergeld, Daniel L. , Sisti, Michael B. , Thompson, Reid C., Waziri, Allen, Sonabend, Adam M , Swanson, Kristin R , Cahill, Daniel P. , Carter, Bob S. , Ghogawala, Zoher , McKhann, Guy M. , Zacharia, Brad E

Neurosurgery | August 10, 2016 | Volume: 80 | Issue: 4 | Pages: 590-601

10.1227/neu.0000000000001374 | PMID 27509070 Get It

Abstract BACKGROUND Extent of resection (EOR) correlates with glioblastoma outcomes. Resectability and EOR depend on anatomical, clinical, and surgeon factors. Resectability likely influences outcome in and of itself, but an accurate measurement of resectability remains elusive. An understanding of resectability and the factors that influence it may provide a means to control a confounder in clinical trials and provide reference for decision making. OBJECTIVE To provide proof of concept of the use of the collective wisdom of experienced brain tumor surgeons in assessing glioblastoma resectability. METHODS We surveyed 13 academic tumor neurosurgeons nationwide to assess the resectability of newly diagnosed glioblastoma. Participants reviewed 20 cases, including digital imaging and communications in medicine-formatted pre- and postoperative magnetic resonance images and clinical vignettes. The selected cases involved a variety of anatomical locations and a range of EOR. Participants were asked about surgical goal, eg, gross total resection, subtotal resection (STR), or biopsy, and rationale for their decision. We calculated a “resectability index” for each lesion by pooling responses from all 13 surgeons. RESULTS Neurosurgeons’ individual surgical goals varied significantly ( P = .015), but the resectability index calculated from the surgeons’ pooled responses was strongly correlated with the percentage of contrast-enhancing residual tumor ( R = 0.817, P < .001). The collective STR goal predicted intraoperative decision of intentional STR documented on operative notes ( P < .01) and nonresectable residual ( P < .01), but not resectable residual. CONCLUSION In this pilot study, we demonstrate the feasibility of measuring the resectability of glioblastoma through crowdsourcing. This tool could be used to quantify resectability, a potential confounder in neuro-oncology clinical trials.
Feasibility of Using Magnetic Resonance Elastography to Study the Effect of Aging on Shear Modulus of Skeletal Muscle
Chen, Qingshan , An, Kai‐Nan , Domire, Zachary J, Domire, Zachary J. , McCullough, Matthew B. A.

Journal of Applied Biomechanics | August 10, 2016 | Volume: 25 | Issue: 1 | Pages: 93-97

10.1123/jab.25.1.93 | PMID 19299834 Get It

A common complication associated with aging is the stiffening of skeletal muscles. The purpose of this study was to determine the ability of magnetic resonance elastography (MRE) to study this phenomenon in vivo. Twenty female subjects were included in the study with an age range of 50 to 70 years. Shear modulus was calculated for the tibialis anterior of each subject. There was not a significant relationship between age and shear modulus. However, three subjects had abnormally high values and were among the oldest subjects tested. There was a significant relationship between age and tissue stiffness homogeneity. More research is needed to determine whether the changes seen here are reflective of increased tissue cross-linking or related to reduced muscle quality. However, MRE shows promise as a tool to study aging-related muscle stiffness changes or to evaluate treatments to counteract these changes.
Character Development and Physical Activity
Morrey, Michael A.

The Sport Psychologist | August 10, 2016 | Volume: 10 | Issue: 3 | Pages: 296-297

10.1123/tsp.10.3.296 Get It

Influence of HLA‐DR polymorphism and allergic sensitization on humoral immune responses to intact pneumococcus in a transgenic mouse model
Sheen, Youn Ho, Rajagopalan, Govindarajan , Snapper, Clifford M. , Kita, Hirohito , Juhn, Young J. , Wi, Chung‐Il , Umaretiya, Puja J. , Kita, H

HLA | August 10, 2016 | Volume: 88 | Issue: 1-2 | Pages: 25-34

10.1111/tan.12851 | PMID 27506953 Get It

AbstractAsthma is independently associated with HLA‐DR3 and increased risks of pneumococcal diseases. We aimed to determine whether HLA‐DR polymorphism (HLA‐DRB1*03), sensitization to house dust mite (HDM), or their interaction affects humoral immune responses to pneumococcal polysaccharide and protein antigens of intact pneumococci. Induction of serum titers of anti‐pneumococcal polysaccharide and anti‐surface protein IgM and IgG in response to immunization with intact pneumococci (Pn) serotype 14 was determined using humanized HLA‐DR3 and DR2 transgenic mice. Transgenic mice were sensitized by injecting HDM and challenged with intranasal HDM. Mice were subsequently immunized with heat‐killed Pn14 at day 24. Serum titers of anti‐phosphorylcholine (PC) IgM and IgG, anti‐pneumococcal polysaccharide, capsular type 14 (PPS14) IgM and IgG, and anti‐pneumococcal surface protein A (PspA) IgG were measured. We included a total of 44 mice (22 DR3 and 22 DR2 mice) and half of mice in each group were sensitized with HDM (i.e. 22 HDM‐sensitized and 22 control mice). HDM‐sensitized mice, irrespective of HLA‐DR polymorphism, had significantly lower humoral immune responses. HLA‐DR3 mice, irrespective of HDM sensitization, elicited a significantly lower anti‐PC IgG response. In contrast, the anti‐PspA IgG response was higher in DR3 relative to DR2 mice. The effect of HDM sensitization on lowering humoral immune responses to Pn14 was observed in DR3 mice regardless of the nature of the antigen, whereas such decreases were observed only for the anti‐PPS14 IgG and anti‐PC IgM responses in DR2 mice. HDM sensitization lowered humoral immune responses to intact pneumococcus and this effect was significantly modified by the HLA‐DR polymorphism.
ETV6 rearrangement in a case of mammary analogue secretory carcinoma of the skin
Chang, Michael , Arthur, Allison K, García, Joaquín J. , Sukov, William R. , Shon, Wonwoo , Arthur, Allison K.

Journal of Cutaneous Pathology | August 10, 2016 | Volume: 43 | Issue: 11 | Pages: 1045-1049

10.1111/cup.12788 | PMID 27506949 Get It

Mammary analog secretory carcinoma of salivary glands is a relatively recently recognized entity that harbors the ETV6‐NTRK3 fusion transcript. To date, only rare cases of mammary analog secretory carcinoma of the skin have been reported. A 57‐year‐old man presented with a 6.0 cm cystic mass in the axilla, involving the dermis and superficial subcutis. Microscopically, the tumor exhibited nodular aggregation of tubular and microcystic structures embedded in the dense fibrotic and hyalinized stroma. Characteristic ‘colloid‐like’ eosinophilic secretory material was present within intraluminal spaces. Tumor cells were largely characterized by vesicular nuclei with inconspicuous nucleoli and pink vacuolated cytoplasm. With respect to immunohistochemistry, tumor cells were intensely positive for AE1/AE3, Cam 5.2, and CK7, whereas Ber‐EP4 and CEA were completely negative. A dual color break‐apart fluorescence in situ hybridization probe identified rearrangement of the ETV6 gene locus on chromosome 12. The patient is alive with no evidence of recurrent disease or metastasis 3 years after the initial surgery. In conclusion, we report a rare example of mammary analog secretory carcinoma of the skin with ETV6 rearrangement. Awareness of this unique cutaneous tumor and subsequent reporting of additional cases is necessary for better characterization of its completely clinicopathologic spectrum.
Erythromelalgia in patients with essential thrombocythemia and polycythemia vera
Hou, Jennifer L., Onajin, Oluwakemi , Gangat, Naseema , Davis, Mark D.P. , Wolanskyj, Alexandra P. , Wolanskyj-Spinner, Alexandra P

Leukemia & Lymphoma | August 10, 2016 | Volume: 58 | Issue: 3 | Pages: 715-717

10.1080/10428194.2016.1205740 | PMID 27684959 Get It

Incidence, Treatment Intensity, and Incremental Annual Expenditures for Patients Experiencing a Cardiac Implantable Electronic Device Infection
Sohail, M. Rizwan , Eby, Elizabeth L. , Ryan, Michael P. , Gunnarsson, Candace , Greenspon, Arnold J. , Wright, Laura A, Wright, Laura A. , Sohail, M Rizwan

Circulation: Arrhythmia and Electrophysiology | August 9, 2016 | Volume: 9 | Issue: 8 | Pages: No page available

10.1161/circep.116.003929 | PMID 27506820 Get It

Background— Because of the increasing use of cardiac implantable electronic devices (CIEDs), it is important to estimate the incidence and annual healthcare expenditures associated with CIED infections. Methods and Results— Patients with a record of an initial or replacement (full implant or generator only) CIED implant during the calendar years 2009 to 2012 in MarketScan Commercial Claims and Medicare Supplemental database were identified. CIED infections were classified into 4 categories: (1) infection not managed by inpatient admission nor implant removal, (2) infection managed by inpatient admission but no implant removal, (3) infection managed by an implant removal either in an inpatient or in an outpatient setting, and (4) infection with severe sepsis and managed in an inpatient setting with implant removal. Using separate models for initial and replacement cohorts, annualized incidence of infection and incremental annual expenditures by treatment intensity were estimated. Cumulative incidence of infection at 1 year post implant was 1.18% for initial CIED implants and 2.37% for replacement. Median time to infection was 35 days for initial and 23 days for replacement. Incremental healthcare expenditures by treatment intensity categories for initial implant patients at 1 year were $16 651, $104 077, $45 291, and $279 744. For replacement patients, incremental expenditures at 1 year by treatment intensity categories were $26 857, $43 541, $48 759, and $362 606. Conclusions— The management of CIED infections results in a substantial healthcare burden with a significant increase in annual expenditures the year after implant when device infection occurs.
Carotid Stenting Versus Carotid Endarterectomy: What Did the Carotid Revascularization Endarterectomy Versus Stenting Trial Show and Where Do We Go From Here?
Lal, Brajesh K. , Howard, George , Brott, Thomas G. , Meschia, James F. , Howard, George

Angiology | August 9, 2016 | Volume: 68 | Issue: 8 | Pages: 675-682

10.1177/0003319716661661 | PMID 27507736 Get It

Although rapidly expanding in its use, carotid artery stenting remains a relatively new procedure. Its growth is due, at least in part, to the perceived advantages of a less invasive technique. However, the clinical effectiveness and specific role for stenting in the treatment of carotid occlusive disease are still under evaluation. The primary aim of the randomized clinical trial, Carotid Revascularization Endarterectomy versus Stenting Trial (CREST), was to contrast the relative efficacy of carotid stenting versus carotid endarterectomy in preventing stroke, myocardial infarction, or death during a 30-day periprocedural period or ipsilateral stroke over the follow-up period in patients with symptomatic and asymptomatic extracranial carotid stenosis. The secondary goals were to describe the differential efficacy of the 2 procedures in men and women, contrast periprocedural (30-day) morbidity and postprocedural morbidity and mortality, estimate and contrast the restenosis rates of the 2 procedures, evaluate differences in measures of health-related quality of life and cost-effectiveness, and identify subgroups of participants at differential risk of stenting or surgery. This report summarizes the results obtained from CREST with respect to its primary and secondary aims.